Mindfulness Training Hidradenitis Suppurativa (HS)

August 29, 2025 updated by: Hadar Lev-Tov, University of Miami

Effectiveness of Mindfulness Training on the Quality of Life of Hidradenitis Suppurativa Patients

The purpose of this research is to investigate the effectiveness of mindfulness training on the quality of life of Hidradenitis Suppurativa (HS) patients. HS can have a profound impact on quality of life.

Study Overview

Study Type

Interventional

Enrollment (Actual)

37

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Miami, Florida, United States, 33136
        • University of Miami

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Hidradenitis Suppurativa patients registered in the University of Miami Hospital dermatology system. Patients can have lesions present at the time of study participation

Exclusion Criteria:

  • Individuals with any of the following: active drug addictions, untreated Post Traumatic Stress Disorder (PTSD), psychosis or suicidal ideations
  • Adults unable to consent
  • Pregnant women
  • Prisoners
  • Individuals below the age of 18 years old
  • Individuals who do not speak English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness Course Group
Participants will participate in the mindfulness course that would last 6 weeks.
Participants will attend a weekly 1.5-hour class over a 6-week period via Zoom. Participants will also be required to listen to guided practice audio recordings that are 12-20 minutes long and complete a weekly homework log detailing all audio recordings completed.
Experimental: HS Educational Course Group
Participants will participate in the mindfulness course that would last 6 weeks.
Participants will meet for 10 -15 minutes once a week over a 6-week period. The course will be administered verbally or with the use of PowerPoint slides.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HS Quality of Life Measure (HiSQOL) Scores
Time Frame: Up to 10 weeks
HS quality of life (HiSQOL) has a total score ranging from 0 to 68, with higher scores indicating more severe impact on participant's quality of life
Up to 10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dermatology Life Quality Index (DLQI) Scores
Time Frame: Up to 10 weeks
Dermatology Life Quality Index (DLQI) has a total score ranging from 0 to 30 with the lower score indicating higher health related quality of life
Up to 10 weeks
Number of participants at each Refined Hurley Classification
Time Frame: Up to 10 weeks
The Hurley Classification is staged as: 1 (single or multiple abscesses without sinus tract formation or scarring); 2 (recurrent abscesses with one or more sinus tracts and scarring widely separated by normal skin); 3 (diffuse involvement with multiple sinus tracts and no intervening normal skin).
Up to 10 weeks
Hidradenitis Suppurativa Physician's Global Assessment Scale (HS-PGA) Scores
Time Frame: Up to 10 weeks
HS Physician's Global Assessment (HS-PGA) Scale is a 6-point Likert scale from 0 (clear) to 5 (very severe). Total score ranges from 0 to 30 with the higher score indicating more severe HS symptoms
Up to 10 weeks
Five-Facet Mindfulness Questionnaire - Short Form (FFMQ-SF) Scores
Time Frame: Up to 10 weeks
FFMQ-SF has total scores ranging from 15 to 75. Higher scores indicate greater levels of mindfulness.
Up to 10 weeks
Pain Visual Analog Scale (VAS) Scores
Time Frame: Up to 10 weeks
Pain VAS has a range from 0 to 10 with a higher score indicating worse pain
Up to 10 weeks
Sleep Quality Scale (SQS) Scores
Time Frame: Up to 10 weeks
Sleep Quality Scale (SQS) has a score ranging from 0-10 with a greater score indicating greater sleep quality
Up to 10 weeks
Number of Pain medication Usage
Time Frame: Up to 10 weeks
Patient reported number of pain medications used by participants in the past week
Up to 10 weeks
Number of work/school days missed
Time Frame: Up to 10 weeks
Patient reported number of work/school days missed in the past week
Up to 10 weeks
Number of visits to the emergency room
Time Frame: Up to 10 weeks
Patient reported number of visits to the emergency room in the past week
Up to 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hadar Lev-Tov, MD, University of Miami

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2023

Primary Completion (Actual)

August 21, 2025

Study Completion (Actual)

August 21, 2025

Study Registration Dates

First Submitted

November 29, 2022

First Submitted That Met QC Criteria

November 29, 2022

First Posted (Actual)

December 8, 2022

Study Record Updates

Last Update Posted (Estimated)

September 2, 2025

Last Update Submitted That Met QC Criteria

August 29, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Mindfulness Course

Subscribe